The use of male slings in the treatment of severe post prostatectomy urinary incontinence: a comparative study in patients with or without radiotherapy

Technical Summary: The Use of Male Slings in Severe Post-Prostatectomy Urinary Incontinence

Problem Statement
Urinary incontinence following radical prostatectomy (PPI) remains a significant complication for prostate cancer patients, with prevalence rates varying widely. While the Artificial Urinary Sphincter (AUS) is considered the gold standard, it carries non-negligible revision rates (over 25% at 3 years) and presents challenges regarding cost, mechanical complexity, and the need for manual operation, particularly in developing countries. Male slings, specifically repositioning urethral devices, have been established for mild incontinence but are increasingly being evaluated for moderate-to-severe cases. A critical clinical question remains regarding the efficacy of these slings in patients with severe PPI, particularly those with a history of prior radiotherapy (RT), which is known to be a negative predictor for surgical success.

Methodology
This was a prospective, observational, non-comparative single-center study conducted in São Paulo, Brazil, between March 2022 and February 2024. The study involved 50 patients with severe post-prostatectomy urinary incontinence who underwent implantation of the Advance XP male sling (Boston Scientific).

• Patient Selection: Inclusion criteria required severe incontinence defined by a 1-hour pad test >75g, >4 pads per day (PPD), or a Standing Cough Test (SCT) grade 3 or 4. Exclusion criteria included mild/moderate PPI, neurological conditions, untreated urethral stenosis, and active malignancies.
• Surgical Protocol: A single surgeon performed all procedures using a standardized technique. A critical technical step involved the release of the central tendon of the perineum (CTP) to achieve at least 3–4 cm of urethral mobilization toward the membranous urethra before sling placement. The device was tensioned to advance the bulbar urethra forward to the bladder neck.
• Data Collection: Patients underwent preoperative urodynamic studies (cystometric capacity, abdominal leak point pressure [ALPP], detrusor overactivity, etc.) and were stratified into two groups: those with prior radiotherapy (RT, n=25) and those without (Non-RT, n=25).
• Outcomes: Assessments at 12 months included Patient Global Impression of Improvement (PGI-I) for satisfaction, social continence (defined as ≤1 pad/day), PPD usage, SCT, and urodynamic parameters.

Key Contributions

• Severe PPI Focus: This study represents one of the first prospective evaluations specifically targeting the Advance XP sling in patients with severe urinary incontinence, a population often excluded from sling trials in favor of mild cases.
• Radiotherapy Stratification: The study explicitly compares outcomes between patients with and without prior RT, addressing a known negative predictor for sling success.
• Technical Emphasis: The authors highlight the importance of urethral mobilization (releasing the CTP) as a critical determinant for surgical success, suggesting that achieving adequate mobilization is essential even in severe cases.
• Urodynamic Predictors: The study identifies cystometric capacity (CC) as a primary predictor of outcomes, potentially more influential than ALPP in this specific cohort.

Results

• Satisfaction: Overall patient satisfaction was high, with a mean score of 86.7% ± 17.1%. There was no statistically significant difference in satisfaction between the RT group (82.3%) and the Non-RT group (90.6%, p=0.146).
• Social Continence: While satisfaction was comparable, social continence rates differed significantly. Patients without prior RT achieved better social continence outcomes compared to the RT group (p=0.02).
• Urodynamic Predictors:
  • ALPP: The RT group presented significantly lower preoperative ALPP (96.9 cmH2O) compared to the Non-RT group (145 cmH2O, p=0.02).
  • Cystometric Capacity (CC): A bladder capacity of <300 ml emerged as the strongest predictor of poorer outcomes. Low CC correlated with higher rates of detrusor overactivity, lower satisfaction, increased early leakage volume, and increased nocturia (p=0.02 for all).
• Post-operative Metrics: There were no significant differences between groups regarding postoperative PPD, SCT, Qmax, or urgency, despite the preoperative differences in ALPP.

Significance and Claims
The paper concludes that the Advance XP male sling is a viable treatment option for patients with severe post-prostatectomy urinary incontinence, achieving high satisfaction rates even in this challenging population. The authors claim that while prior radiotherapy negatively impacts objective social continence rates, it does not diminish overall patient satisfaction, suggesting that the procedure still offers a meaningful improvement in quality of life for these patients.

The study posits that the Advance XP may serve as a more accessible and cost-effective alternative to the AUS, particularly in developing countries where the latter is less available. The authors attribute their favorable outcomes to the rigorous surgical technique, specifically the mandatory mobilization of the urethra. However, the paper maintains a modest tone, acknowledging limitations such as the small sample size and short follow-up period, and calls for further large-scale prospective studies to validate these findings.